Floatz logo

Fluconazole

Invasive Fungal Infections

Radboud University Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Invasive Fungal Infections cohort.

Asset / SponsorPhaseRating
Isavuconazole
Astellas Pharma Inc
Phase 3BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Fosmanogepix
Basilea Pharmaceutica
Phase 2CCC
MICAFUNGIN
Astellas Pharma Europe B.V.
D

Same molecule, other indications

Fluconazole is also rated in:

candidiasis, invasiveDormant
BB
Indicative ·
69 / 100
View asset →
FluconazoleDormant
BB
Indicative ·
69 / 100
View asset →
Cystic FibrosisDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →